BFRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Biofrontera Inc (BFRI) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. The technical indicators show a neutral to slightly bullish trend, but the lack of significant trading trends, recent news, or positive financial performance makes it less compelling as an immediate investment opportunity.
The MACD histogram is positive at 0.0187, indicating a bullish trend, but it is contracting. RSI is at 72.523, which is in the neutral zone. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are R1: 1.079 and R2: 1.128, while support levels are S1: 0.918 and S2: 0.869. Stock trend analysis suggests a 60% chance of minor declines in the next day (-0.97%), week (-1.74%), and month (-3.73%).
Bullish moving averages and a positive MACD histogram. Gross margin increased by 42.02% YoY in Q4 2025.
No recent news or significant trading trends. Stock trend analysis indicates a likelihood of minor declines in the short term.
In Q4 2025, revenue increased by 36.16% YoY to $17,100,000. However, net income dropped significantly by -504.01% YoY to $5,640,000, and EPS declined by -366.67% YoY to 0.48. Gross margin improved by 42.02% YoY to 82.4%.
No recent analyst ratings or price target changes available.
